Article Details
Retrieved on: 2025-03-09 16:29:48
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the variability in Medicaid coverage for JAK inhibitors used to treat alopecia areata, highlighting Hawaii as the only state with unrestricted coverage for drugs like Olumiant and Litfulo, related to hair loss and autoimmune conditions.
Article found on: www.managedhealthcareexecutive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here